BCAX

Bicara Therapeutics
BCAX

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$11
39% downside
High target

1 analyst rating

positive
1  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wells Fargo
Wells Fargo
Eva Fortea Verdejo
0% 1-yr BCAX win rate
11 Nov ‘25 22 days ago